Hyperphosphatemic Familial Tumoral Calcinosis.
Ramnitz MS, Gafni RI, Collins MT.
2018 Feb 1. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.
Hyperphosphatemic familial tumoral calcinosis in a dancer.
Li WX, Stanek J.
PM R. 2023 May;15(5):685-687. doi: 10.1002/pmrj.12818. Epub 2022 Jun 15.
Familial tumoral calcinosis: a valuable vehicle for discovery.
Moe OW.
Nephrol Dial Transplant. 2014 Dec;29(12):2155-7. doi: 10.1093/ndt/gfu270. Epub 2014 Aug 21.
Familial tumoral calcinosis.
Alkhatib A, Burton LE, Carachi R.
Scott Med J. 2014 Nov;59(4):e17-20. doi: 10.1177/0036933014557416. Epub 2014 Oct 27.
Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action.
Folsom LJ, Imel EA.
Curr Osteoporos Rep. 2015 Apr;13(2):78-87. doi: 10.1007/s11914-015-0254-3.
Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis.
Chefetz I, Sprecher E.
Biochim Biophys Acta. 2009 Sep;1792(9):847-52. doi: 10.1016/j.bbadis.2008.10.008. Epub 2008 Oct 25.
Hyperphosphatemic familial tumoral calcinosis mimicking a cystic hemo-lymphangioma on MRI.
Houss SE, LRhorfi N, Yousfi ZE, Haddad SE, Chat L, Allali N, Rguieg N, Lamalmi N.
Radiol Case Rep. 2022 Sep 28;17(12):4603-4607. doi: 10.1016/j.radcr.2022.08.071. eCollection 2022 Dec.
Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.
Chakhtoura M, Ramnitz MS, Khoury N, Nemer G, Shabb N, Abchee A, Berberi A, Hourani M, Collins M, Ichikawa S, El Hajj Fuleihan G.
Osteoporos Int. 2018 Sep;29(9):1987-2009. doi: 10.1007/s00198-018-4574-x. Epub 2018 Jun 20.
Hyperphosphataemic tumoral calcinosis.
Tiwari V, Goyal A, Nagar M, Santoshi JA.
Lancet. 2019 Jan 12;393(10167):168. doi: 10.1016/S0140-6736(18)33045-9.
Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and alphaKlotho).
Farrow EG, Imel EA, White KE.
Best Pract Res Clin Rheumatol. 2011 Oct;25(5):735-47. doi: 10.1016/j.berh.2011.10.020.
